CDSCO: how India regulates drugs, medical devices and cosmetics

The Central Drugs Standard Control Organization (CDSCO) is India's central regulator for drugs, medical devices and cosmetics under the Drugs and Cosmetics Act, 1940. The Drugs Controller General (India), or DCGI, heads it. CDSCO decides device imports, Class C and D manufacture, new drugs, trials and cosmetic imports; state drugs controllers license Class A and B device making and sale.

Published and updated

A laboratory technician in a blue gown, gloves and a green hairnet holds a sample tube up to the light, a whiteboard and shelves blurred behind her.

Share your requirement with our desk. We will respond with a clear scope and a practical path forward.

Talk to our desk about CDSCO

Where do CDSCO's rules stand on November 8, 2026?

On November 8, 2026, CDSCO's rules rest on the Drugs and Cosmetics Act, 1940 and its rules. In 2026 European Union approvals joined the waiver for new devices, imported drugs began to need a year of shelf life, and CDSCO started rejecting long-pending applications left unanswered after three reminders.

As of November 8, 2026

We read 56 official texts on November 8, 2026. They include the Act, the rules, the 2024 to 2026 Gazette notifications, CDSCO's FAQs and notices, and a Central Board of Indirect Taxes and Customs (CBIC) circular. CDSCO's compilations lag, so we cite each later amendment.

Changes since September 2025:

CDSCO guides, and what each answers
GuideWhat it answers
Medical device registration in IndiaClasses, licences and the Class A route
Medical device import licenceForms MD-14 and MD-15
The Indian authorized agentWhat foreign makers need
Medical device manufacturing licenceForms MD-5 and MD-9
Medical device labelingLabels, and what you report after approval
Drug import licenceForm 41 registration and Form 10
Clinical trial approvalForms CT-04 and CT-06, and new drug permission
Cosmetics registrationImporting under COS-1 and COS-2

What is CDSCO, and what do the state drugs controllers decide?

CDSCO is the central regulator under the Drugs and Cosmetics Act, 1940. Its head, the DCGI, licenses devices centrally: imports of every class, Class C and D manufacture, clinical investigations and new IVDs. Each state's drugs controller licenses Class A and B device makers and cosmetic factories, and registers device sellers. CDSCO registers imported cosmetics.

Who decides what (MDR: the Medical Devices Rules, 2017)
ActivityAuthorityFormRule
Import any class of deviceCDSCOMD-14 for an MD-15 licenceMDR rules 8(1), 34 and 36, opens in a new tab
Make Class A or B devicesThe state's drugs controllerMD-3 for an MD-5 licenceMDR rules 8(2) and 20
Make Class C or D devicesCDSCOMD-7 for an MD-9 licenceMDR rules 21 and 25
Sell devicesThe state's drugs controllerMD-41 for an MD-42 registrationMDR rule 87A
Register imported cosmeticsCDSCOCOS-1 for a COS-2 certificateCosmetics Rules, 2020, rules 4(1), 12 and 13, opens in a new tab
License cosmetic factories and oversee cosmetics on saleThe state's licensing authorityA state licence to manufactureCosmetics Rules, 2020, rule 4(2)
Register and license drug importsA licensing authority the central government appointsForm 40 for a Form 41 certificate; Form 8 for a Form 10 licenceDrugs Rules, 1945, rules 21 to 24A, opens in a new tab
Approve clinical trials and new drugsCDSCO, the DCGICT-04 for a CT-06 trial permissionNew Drugs and Clinical Trials Rules, 2019, rules 21 and 22, opens in a new tab

Since 2020 every medical device is regulated under the Medical Devices Rules, 2017, which override the older Drugs Rules where the two conflict (rule 96; device FAQ, question 1, opens in a new tab). CDSCO runs a public relations cell in New Delhi for device startups, importers and makers (question 7).

Is your product a drug, a medical device or a cosmetic?

The Drugs and Cosmetics Act, 1940 decides it. A cosmetic is anything rubbed, poured, sprinkled or sprayed on the body to clean, beautify, add attractiveness or change appearance. A device counts as a drug once the government notifies it. A product given as an injection isn't a cosmetic, CDSCO said in May 2026.

Software that meets the device definition is a device, standalone software included: see medical device registration in India.

What are India's medical device risk classes?

Medical devices fall into four risk classes under rule 4 of the Medical Devices Rules, 2017: A (low), B (low moderate), C (moderate high) and D (high). In vitro diagnostic devices use the same four classes under their own parameters. Only CDSCO's Central Licensing Authority classifies a device; a maker can't set its own class.

Device risk classes, and who licenses their manufacture
ClassRiskManufacturing licence from
Class ALowThe state; registration only, if non-sterile and non-measuring
Class BLow moderateThe state
Class CModerate highCDSCO
Class DHighCDSCO

CDSCO classifies by intended use (rule 4(3), opens in a new tab) and, where another country classes a device differently, may apply the higher class (device FAQ, question 93, opens in a new tab); see medical device registration in India.

Which approval does a medical device need?

A medical device needs the approval that matches what you do with it. Class A non-sterile, non-measuring devices are registered on CDSCO's portal. Every other import needs an MD-15 licence, making a device needs a state or central manufacturing licence by class, and a shop selling only devices needs an MD-42 registration.

Device approvals by activity, under the Medical Devices Rules, 2017
What you doApplicationApprovalRule
Make or import a Class A non-sterile, non-measuring deviceDetails on the online portalA registration numberRules 19G to 19K, opens in a new tab
Import any other deviceForm MD-14Licence in Form MD-15Rules 34 and 36
Make Class A or B devicesForm MD-3 (MD-4 for a loan licence)Form MD-5 or MD-6Rule 20
Make Class C or D devicesForm MD-7 (MD-8 for a loan licence)Form MD-9 or MD-10Rules 21 and 25
Sell devices onlyForm MD-41Registration in Form MD-42Rule 87A
Make devices to test, demonstrate or trainForm MD-12Test licence in Form MD-13, for three yearsRule 31
Import devices to test, demonstrate or trainForm MD-16Test licence in Form MD-17, for three yearsRules 40 and 41

What does a new device with no predicate need?

A new medical device with no predicate needs a clinical investigation permitted in Form MD-23, then MD-27 permission before any import or manufacturing licence. The authority may waive the investigation for a device approved and marketed for at least two years in the UK, the US, Australia, Canada, Japan or, since August 2026, the EU.

How do you import medical devices into India?

To import a medical device, an authorized agent in India files Form MD-14 online, and CDSCO decides on the import licence, Form MD-15, within nine months under rule 36(1). Every class needs it, except Class A non-sterile, non-measuring devices. The licence has no end date while a retention fee is paid every five years.

  1. 1. Appoint an Indian authorized agent by power of attorney.
  2. 2. Get a free sale certificate; one from Australia, Canada, Japan, the European Union, the UK or the US needs no clinical investigation (rule 36(3), opens in a new tab).
  3. 3. From any other country, Class C and D need a clinical investigation in India (rule 36(4)). Class A and B need published data or an investigation abroad, plus a home-country free sale certificate (rule 36(5)).
  4. 4. File Form MD-14 on the portal, through the agent, and answer CDSCO's questions until it decides on Form MD-15.

The medical device import licence guide covers the dossier, inspection and later importers.

What does a foreign maker need in India?

A foreign device maker sells in India through an Indian authorized agent, appointed by power of attorney, who holds the MD-15 import licence. Changing that agent needs a fresh import licence. For cosmetics, the foreign maker may apply itself or through its agent, an importer or an Indian subsidiary it authorizes.

Sources: Medical Devices Rules, rule 3(f), opens in a new tab, CDSCO's device FAQ, question 104, opens in a new tab and Cosmetics Rules, rule 12(2), opens in a new tab. The Indian authorized agent covers what the agent holds and signs.

How is making medical devices in India licensed?

Making medical devices in India needs a licence by class. The state licenses Class A and B makers in Form MD-5, after a Notified Body audit for Class B. CDSCO licenses Class C and D makers in Form MD-9. The licences have no end date while a retention fee is paid.

The medical device manufacturing licence guide covers the quality system, staff and audits.

What do device labels and post-market rules require?

Chapter VI of the Medical Devices Rules, 2017 sets what a device label shows: the name, the maker and factory address, the quantity, dates, batch number, sterility and warnings. After approval, an importer gets a major change approved, or deemed approved after sixty days, and reports a minor change within thirty days.

See rule 44, opens in a new tab for labels and rule 38(1)(v) to (vii) for changes. Medical device labeling in India covers stickers, shelf life, recalls and change lists.

How do devices reach hospitals and buyers?

Devices reach buyers through sellers the state has registered. A shop or distributor dealing only in devices needs a Form MD-42 registration from the state; a wholesale drug licence also covers devices. CDSCO asked buyers, hospitals included, in November 2025 to require a CDSCO or state licence when they buy devices.

How do you import drugs into India?

Importing a drug for sale takes two approvals under the Drugs Rules, 1945: a registration certificate in Form 41 for the foreign factory and its drugs, and an import licence in Form 10. Each lasts three years. Since October 2026, an imported drug needs a year of shelf life left.

  1. 1. Apply on Form 40 for the registration certificate, through the maker's authorized agent in India, or as the maker with an Indian wholesale licence (rule 24A(1), opens in a new tab).
  2. 2. Apply on Form 8 for the import licence, with the Form 41 certificate and the maker's undertaking in Form 9 (rule 24).
  3. 3. Ship drugs with a year of shelf life left, or 60% for biologicals and radiopharmaceuticals (G.S.R. 951(E), opens in a new tab).
  4. 4. Apply for fresh ones before the three years end (rules 28 and 28A).

The drug import licence guide covers Schedule X drugs, test licences and renewal.

How are new drugs and clinical trials approved?

A clinical trial of a new drug needs permission from the Central Licensing Authority: you apply on Form CT-04 and receive Form CT-06. The authority decides within ninety working days, or the permission is deemed granted. Importing a new drug for sale needs permission on Form CT-18, granted in Form CT-19 or CT-20.

A local trial may be waived for a drug approved and marketed in countries named under rule 101, with no major unexpected serious adverse events (New Drugs and Clinical Trials Rules, 2019, rule 75(7), opens in a new tab).

The clinical trial approval guide covers ethics committees, bioavailability and bioequivalence (BA/BE) studies, and the 2026 routes.

How are imported cosmetics registered in India?

No cosmetic may be imported into India unless CDSCO has registered it. The maker, its authorized agent, the importer or an Indian subsidiary applies online on Form COS-1, and CDSCO grants a COS-2 certificate, or rejects it, within six months. COS-2 has no end date while a retention fee is paid.

See rules 12 to 14 of the Cosmetics Rules, 2020, opens in a new tab. No cosmetic tested on animals after November 12, 2014 may be imported (rule 18(4)). The cosmetics registration guide covers labels, COS-4A numbers and the 2026 cancellations.

How do CDSCO applications work, and when are they rejected?

Device applications go online through CDSCO's medical devices portal or the National Single Window System (NSWS). Drug, trial and cosmetic applications go on CDSCO's SUGAM portal. Since January 2026, a long-pending SUGAM application left waiting on the applicant gets three reminders thirty days apart, then a fourth notice rejects it and forfeits the fee.

CDSCO's cosmetics FAQ, opens in a new tab still says there is no time limit to answer on a cosmetics application; the 2026 notices are the later word.

What do CDSCO and Customs check at the port?

At the port, CDSCO's port office gives a no objection and Customs clears the goods. Drugs, devices and cosmetics enter India only through the places listed in rule 43A of the Drugs Rules, 1945. Since September 2026, Customs officers check CDSCO's checklists on "PGA facilitated" bills of entry before release.

Duty and the bill of entry are on customs in India, and import restrictions on India import policy.

What enforcement and quality rules apply?

The Drugs and Cosmetics Act bars importing misbranded, adulterated or spurious drugs and misbranded or spurious cosmetics, and lets the central government ban a drug or cosmetic in the public interest. It banned 16 fixed dose combinations in June 2026. Some offenses may be compounded under section 32B.

What time limits do CDSCO's rules set?

CDSCO's rules set their own time limits. An MD-15 import licence is decided within nine months, a COS-2 cosmetic registration within six, and trial permission within ninety working days. These are the government's own limits, counted as each rule counts them, not a promise of a decision by a date.

Time limits in CDSCO's rules, as of November 8, 2026
What is decidedLimitCounted fromRule
MD-15 device import licence9 monthsApplicationMedical Devices Rules, rule 36(1), opens in a new tab
IVD import and test licencesDraft only: 270 days for MD-14, 30 days for MD-16ApplicationDraft IVD guidance, section 11, opens in a new tab
Class C or D manufacturing licenceScrutiny 45 days; inspection 60 days; decision 45 daysThe application; then the inspection reportRules 21(4), 23(1), 25(1)
Class B manufacturing licenceAudit 90 days; report 30 days; decision 20 daysThe application; the audit; its reportRule 20(6)
Device test licence, MD-13 or MD-1730 daysApplicationRules 31(3) and 41(1)
Device with no predicate, MD-27120 days, plus up to 30ApplicationRule 63(2)
Personal use permit for a device7 daysApplicationRule 43(3)
Appeal against most device refusals45 days to fileThe orderRules 20(7), 25(2), 30(2), 36(2)
Form 41 drug registration certificate9 months, plus up to 3A complete applicationDrugs Rules, rule 27A(1), opens in a new tab
COS-2 registration or COS-4A number6 monthsApplicationCosmetics Rules, rules 13(1), 17(2), opens in a new tab
Clinical trial permission, CT-0690 working days; 30 for a drug discovered, or researched and made, in IndiaApplicationNDCT Rules, rules 22(2) and 23, opens in a new tab
New drug import permission90 working daysThe CT-18 applicationNDCT Rules, rule 76(1)
Port office no objection2 to 3 hours on documents; 24 to 48 with a physical check; 48 to 72 with lab testingNot statedCDSCO notice of September 10, 2021, opens in a new tab

Which CDSCO dates are coming up?

The next CDSCO date is mid-February 2027, when device labels must show the licence number of an outsourced sterilization site. The Jan Vishwas Act, 2026 changes to the Drugs and Cosmetics Act start on June 30, 2027, and Schedule H2 widens on July 1, 2027 and July 1, 2028.

CDSCO dates ahead, as of November 8, 2026
DateWhatSource
From mid-February 2027Labels show an outsourced sterilization site's licence numberWorked out: six months from G.S.R. 743(E), opens in a new tab of August 14, 2026
June 30, 2027Jan Vishwas Act, 2026 changes to the Drugs and Cosmetics Act startS.O. 3286(E), opens in a new tab
July 1, 2027Schedule H2 covers vaccines, narcotic and psychotropic drugs and anticancer drugsG.S.R. 506(E), opens in a new tab
July 1, 2028Schedule H2 covers all antimicrobialsG.S.R. 506(E), opens in a new tab

Drafts not yet final: G.S.R. 515(E), opens in a new tab (device licence timelines), 509(E), opens in a new tab (drug test licences), 790(E), opens in a new tab (BA/BE studies) and 954(E), opens in a new tab, 955(E), opens in a new tab and 956(E), opens in a new tab of October 28, 2026.

What do pages online get wrong about CDSCO's rules?

Pages online often repeat CDSCO rules that changed or never existed: an MD-15 licence that expires after five years, Class A registration called voluntary, a trial approval time halved in 2026, and 60% shelf life for every imported drug. The table sets 13 such claims beside what the official documents say.

Claims online, and what the documents say (MDR: Medical Devices Rules)
What some pages sayWhat the documents sayRule
An MD-15 import licence is valid for five yearsNo end date while the retention fee is paid every five yearsMDR rule 37, opens in a new tab
A COS-2 cosmetic registration is valid for three or five yearsNo end date while the retention fee is paidCosmetics Rules, rule 14(1), opens in a new tab
Registering a Class A non-sterile, non-measuring device is voluntaryMandatory and free; the portal issues the numberMDR rules 19G to 19K
MD-14 is the licence for Class A and B devices and MD-15 for Class C and DMD-14 is the application and MD-15 the licence, for every classMDR rules 34(1), 36(1)
CDSCO grants manufacturing licences for Class A and B devicesThe state licenses Class A and B; CDSCO licenses C and DMDR rules 8, 20, 21
An import licence officially takes four to six monthsAn outer limit of nine months; no rule sets four to sixMDR rule 36(1)
The January 2026 amendment halved the time to approve a clinical trialTrial permission still has ninety working daysNDCT rule 22(2), opens in a new tab; G.S.R. 46(E), opens in a new tab
Only five countries' approvals count for a device with no predicateEuropean Union approvals count too, since August 2026G.S.R. 744(E), opens in a new tab
Imported drugs need 60% of their shelf life leftOne year since October 2026; 60% for biologicalsG.S.R. 951(E), opens in a new tab
Changing your Indian distributor only needs a letter to CDSCOA new Indian agent needs a fresh import licenceDevice FAQ, question 104, opens in a new tab
Imported cosmetics are registered on Form 42 and Form 43COS-1 and COS-2, since the Cosmetics Rules, 2020Cosmetics Rules, rules 12(2), 13(1)
Only notified devices need a licence; the rest just registerAll devices need a licence, except Class A non-sterile, non-measuring onesDevice FAQ, question 2
A device licence lets you import through any portOnly through ports notified under the Drugs Rules, 1945Device FAQ, question 106

Where do BIS, DGFT, Customs, MoEFCC and NPPA come in?

Other agencies' rules sit beside CDSCO's. A device must meet the Bureau of Indian Standards (BIS) standard where one exists, and cosmetics on the Ninth Schedule, hair dyes included, must meet theirs. Import policy, customs duty, e-waste rules and drug prices belong to other bodies.

How IndusDesk helps with CDSCO

Share your requirement with our desk. We will respond with a clear scope and a practical path forward.

CDSCO and the states decide, so we never promise a licence, a registration or a date.

We aren't anyone's authorized agent or importer, and we never appear before an appellate authority or a court.

Frequently asked questions

What is the difference between CDSCO and the DCGI?

CDSCO is the organization; the Drugs Controller General (India), the DCGI, heads it. The DCGI is the Central Licensing Authority under the device rules and the trial rules.

Do I go to CDSCO or the state drugs controller?

It depends on the activity. Go to CDSCO for device imports, Class C and D manufacture, new drugs, trials and cosmetic imports, and to the state for Class A and B manufacture and device sales.

Can a consultant check my application status with CDSCO?

No. CDSCO says only an authorized person of the company may ask about a device application's status (device FAQ, question 11). A consultant prepares the papers; the company asks.

What happens if I don't answer CDSCO's questions on my application?

On a long-pending SUGAM application, CDSCO sends three reminders, thirty days apart, then a fourth notice rejects the application and the fee is forfeited. Its notice of January 16, 2026 set this out.

Which portal do I use for a CDSCO application?

Devices go through CDSCO's medical devices portal or the NSWS. Drugs, clinical trials and cosmetics go through SUGAM.

Can I appeal a CDSCO refusal?

For devices, yes: most refusals and cancellations under the Medical Devices Rules may be appealed to the State or Central Government within 45 days. A debarment for fake documents carries an appeal within thirty days.

Sources